GlassScriptPhysician profile
Brandon Lunsford
NPI 1154085819
$4,442.51
in general payments reported to CMS, 2019-2025
33 companies · $854 in 2025
The $854 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.64 · 2022: $1,955 · 2023: $787 · 2024: $800 · 2025: $854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,381 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,381.26 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,039.91 | 2022-2025 | |
| Lilly USA, LLC | $595.66 | 2021-2025 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $365.43 | 2021-2025 | Farxiga, Airsupra |
| Mannkind Corporation | $333.71 | 2022-2024 | Afrezza |
| Xeris Pharmaceuticals, INC. | $176.11 | 2021-2025 | Gvoke Hypopen |
| Novo Nordisk INC | $162.00 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $145.41 | 2023-2025 | Nuedexta, Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $139.23 | 2022-2024 | |
| Insulet Corporation | $135.96 | 2022-2025 | Omnipod |
| Lundbeck LLC | $124.98 | 2023 | Vyepti |
| Cequr Corporation | $117.54 | 2022 | |
| Sanofi-Aventis U.S. LLC | $113.12 | 2022-2025 | |
| Philips North America LLC | $100.77 | 2024 | (5050) Extended Holter |
| Exact Sciences Corporation | $98.73 | 2023-2024 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $88.46 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zealand Pharma US, INC. | $83.58 | 2022 | |
| Amgen INC. | $71.34 | 2022-2025 | Otezla, Repatha, Otezla |
| Ultragenyx Pharmaceutical INC. | $67.50 | 2022 | |
| Corcept Therapeutics | $66.59 | 2022 | |
| Medtronic, INC. | $64.68 | 2022 | |
| Eusa Pharma (US) LLC | $57.53 | 2022 | |
| Recordati_rare_diseases_inc. | $57.53 | 2022 | |
| Grt US Holding, INC. | $43.48 | 2022 | |
| Radius Health, INC. | $41.22 | 2022 | |
| Antares Pharma, INC. | $30.75 | 2022 | |
| Globus Medical, INC. | $24.46 | 2025 | Senza |
| Merck Sharp & Dohme LLC | $16.72 | 2022 | |
| Currax Pharmaceuticals LLC | $14.98 | 2025 | Contrave |
| Lifescan, INC. | $14.75 | 2022 | |
| Dexcom, INC. | $13.79 | 2024 | Dexcom G6 Transmitter |
| Ipsen Biopharmaceuticals, INC | $13.55 | 2022 | |
| Esperion Therapeutics, INC. | $12.96 | 2022 | |
| Tandem Diabetes Care, INC. | $10.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Lunsford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.